SCYNEXIS Announces Positive Interim Results from Phase 3 Open-Label FURI Study, Showing Oral Ibrexafungerp’s Ability to Treat Refractory Fungal Infections and to Provide an Alternative to Long-Term IV Therapies 글 내용 전체보기
Orthopaedic Imaging Equipment Market is Expected to Register a CAGR of 4.9% During the Forecast Period 2016-2026 글 내용 전체보기
Lap Dances From an Insys Sales Executive Were Part of Insys’ Practices to Boost Sales of Subsys, Trial Shows 글 내용 전체보기
